Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Aztreonam/Colistin

Delayed hypersensitivity in the form of rash and renal impairment

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Nageshwaran V, et al. Surgical source control and colistin therapy for the management of osteomyelitis due to Pseudomonas aeruginosa with difficult-to-treat resistance. JAC-Antimicrobial Resistance 5 (Suppl. 2): ii7-ii8 abstr. dlad066.018, Jun 2023. Available from: URL: https://dx.doi.org/10.1093/jacamr/dlad066.018 [abstract] Nageshwaran V, et al. Surgical source control and colistin therapy for the management of osteomyelitis due to Pseudomonas aeruginosa with difficult-to-treat resistance. JAC-Antimicrobial Resistance 5 (Suppl. 2): ii7-ii8 abstr. dlad066.018, Jun 2023. Available from: URL: https://dx.doi.org/10.1093/jacamr/dlad066.018 [abstract]
Metadaten
Titel
Aztreonam/Colistin
Delayed hypersensitivity in the form of rash and renal impairment
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-55462-x

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Nilotinib

Case report

Heparin

Case report

Multiple drugs

Case report

Antineoplastics

Case report

Tamoxifen